semaglutide bmi md reviews A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the bmiMD | GLP-1 & Anti-Aging

Document injection-site reactions (redness, itching, nodules) and rotate injection sites regularly

PMID: 39387733

This claim is based on the results of clinical trials that evaluated the effects of the weight loss medications offered through the Ro Body Program, including Zepbound (tirzepatide) and Wegovy (semaglutide)

innocua cells on lettuce leaves decreased by more than 3-log after washing with ELA solution (0.1% w/w) for 20 min with shaking at 200 rpm (Huang and Nitin, 2017)

One months supply of Wegovy can cost upwards of $1,000, making it a large expense for many people who would like to include this medication as part of their weight management regimen